EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis

Emanuela Anastasi iD, Antonella Farina iD, Teresa Granato, Flavia Colaiacovo iD, Beatrice Pucci iD, Sara Tartaglione, Antonio Angeloni

International Journal of Molecular Sciences · 22.06.2023 · 24 (13) · 10479

DOI: 10.3390/ijms241310479 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.06.2023. Verfasst von Emanuela Anastasi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy. Hauptthemen laut MEDLINE: Proteins, Ovarian Neoplasms. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Currently, ovarian cancer (OC) is a target of intense biomarkers research because of its frequent late diagnosis and poor prognosis. Serum determination of Human epididymis protein 4 (HE4) is a very important early detection test. Most interestingly, HE4 plays a unique role in OC as it has been implicated not only in OC diagnosis but also in the prognosis and recurrence of this lethal neoplasm, actually acting as a clinical biomarker. There are several evidence about the predictive power of HE4 clinically, conversely less has been described concerning its role in OC oncogenesis. Based on these considerations, the main goal of this review is to clarify the role of HE4 in OC proliferation, angiogenesis, metastatization, immune response and also in the development of targeted therapy. Through a deeper understanding of its functions as a key molecule in the oncogenetic processes underlying OC, HE4 could be possibly considered as an essential resource not only for diagnosis but also for prognosis and therapy choice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteinsOvarian NeoplasmsHumansFemaleBiomarkers, TumorCarcinogenesisCell Transformation, NeoplasticCA-125 Antigen

Stichwörter der Autor:innen

HE4oncogenesisovarian cancertarget therapy

Substanzen

ProteinsBiomarkers, TumorCA-125 Antigen

Autor:innen und Institutionen

  • Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.
  • CNR-IBPM, Institute of Molecular Biology and Pathology, Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy.

ORCID-Profile: Emanuela Anastasi, Antonella Farina, Flavia Colaiacovo, Beatrice Pucci

Zitieren

APA

Anastasi, E., Farina, A., Granato, T., Colaiacovo, F., Pucci, B., Tartaglione, S., & Angeloni, A. (2023). Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis. International Journal of Molecular Sciences, 24(13), 10479. https://doi.org/10.3390/ijms241310479

Vancouver

Anastasi E, Farina A, Granato T, Colaiacovo F, Pucci B, Tartaglione S, et al. Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis. International Journal of Molecular Sciences. 2023;24(13):10479. doi:10.3390/ijms241310479

BibTeX
@article{Anastasi2023,
  author = {Anastasi, Emanuela and Farina, Antonella and Granato, Teresa and Colaiacovo, Flavia and Pucci, Beatrice and Tartaglione, Sara and Angeloni, Antonio},
  title = {Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {13},
  pages = {10479},
  doi = {10.3390/ijms241310479}
}
Kostenlos starten →